利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

52 条记录 (耗时 0.037 秒)

    Systems and methods for calculating specified matrices
    21.
    发明申请
    Systems and methods for calculating specified matrices 有权
    用于计算指定矩阵的系统和方法

    公开(公告)号：US20060280302A1

    公开(公告)日：2006-12-14

    申请号：US11443096

    申请日：2006-05-31

    申请人： Marcus Baumann ,  Markus Kahn

    发明人： Marcus Baumann ,  Markus Kahn

    IPC分类号： H04N7/167

    CPC分类号： G06Q40/025 ,  G06Q10/063 ,  G06Q40/00 ,  G06Q40/02

    摘要： Computer-implemented methods, computer systems, and computer program products are provided for determining specified matrices. The matrices may be associated with financial institutions and the financial affairs in a banking practice. In one implementation, a base matrix is formed which may be used to create the specified matrices when processing mass data.

    摘要翻译： 提供计算机实现的方法，计算机系统和计算机程序产品用于确定指定的矩阵。 矩阵可能与金融机构和银行业务中的财务有关。 在一个实现中，形成基本矩阵，其可以在处理质量数据时用于创建指定的矩阵。

    Systems and methods for general aggregation of characteristics and key figures
    22.
    发明申请
    Systems and methods for general aggregation of characteristics and key figures 有权

    公开(公告)号：US20060069632A1

    公开(公告)日：2006-03-30

    申请号：US11239139

    申请日：2005-09-30

    申请人： Markus Kahn ,  Marcus Baumann

    发明人： Markus Kahn ,  Marcus Baumann

    IPC分类号： G06Q40/00

    CPC分类号： G06Q40/00 ,  G06Q20/108 ,  G06Q40/02 ,  G06Q40/025 ,  G06Q40/06 ,  Y10S707/99935

    摘要： Computer-implemented methods, computer systems, and computer programs product are provided for automated generic and parallel aggregation of characteristics and key figures of unsorted mass data being of specific economic interest, particularly associated with financial institutions, and with financial affairs in banking practice. The parallel aggregation may reduce the amount of data for a customer defined granularity for the purpose of facilitating the handling of raw data related to all areas of credit risk management in banking practice. Moreover, the computing power of software and the software performance run time, respectively, may be improved in the case of mass data.

    Substituted tetrathiotetracenes and tetraselenotetracenes
    26.
    发明授权
    Substituted tetrathiotetracenes and tetraselenotetracenes 失效

    公开(公告)号：US4981962A

    公开(公告)日：1991-01-01

    申请号：US356824

    申请日：1989-05-24

    申请人： Marcus Baumann ,  Walter Fischer ,  Vratislav Kvita ,  Carl W. Mayer ,  Wolfgang Wernet

    发明人： Marcus Baumann ,  Walter Fischer ,  Vratislav Kvita ,  Carl W. Mayer ,  Wolfgang Wernet

    IPC分类号： B05D1/20 ,  C07D495/06 ,  C07D517/06 ,  C07D517/16 ,  C08G61/12 ,  C09K9/02 ,  H01B1/12

    CPC分类号： C07D495/06 ,  B05D1/202 ,  B82Y30/00 ,  B82Y40/00 ,  C07D517/06 ,  C07D517/08 ,  C08G61/123 ,  C09K9/02 ,  H01B1/121

    摘要： Substituted tetrathiotetracenes and tetraselenotetracenes of the formula I ##STR1## in which Z is --S-- or --Se-- and (a) R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are H and R.sup.5 to R.sup.8 are each H and at least one of the radicals R.sup.5 to R.sup.8 independently of one another is a substituent belonging to the group comprising C.sub.1 -C.sub.20 alkyl--X--.sub.p which is unsubstituted or substituted by halogen, --CN, --CONR.sup.9 R.sup.10, --OR.sup.9, --SR.sup.9 or --COOR.sup.9, with the exception of C.sub.1 -C.sub.4 alkyl and methoxy, C.sub.2 -C.sub.18 alkenyl--X--.sub.p, C.sub.2 -C.sub.18 -alkynyl--X--.sub.p, C.sub.3 -C.sub.8 cycloalkyl--X--.sub.p, (C.sub.1 -C.sub.12 alkyl)--C.sub.3 -C.sub.8 cycloalkyl--X--.sub.p, C.sub.3 -C.sub.8 cycloalkyl-C.sub.r H.sub.2r --X--.sub.p, (C.sub.1 -C.sub.12 alkyl)-C.sub.3 -C.sub.8 -cyclo alkyl-C.sub.r H.sub.2r --X--.sub.p, phenyl--X--.sub.p, (C.sub.1 -C.sub.12)alkyl)-phenyl--X--, phenyl-C.sub.r H.sub. 2r --X--.sub.p and (C.sub.1 -C.sub.12 alkyl)-phenyl-C.sub.r H.sub.2r --X--.sub.p, r is 1 or 2 and p is 0 or 1 and X is --O--, --S--, --SO-- or --SO.sub.2 --, or R.sup.5 to R.sup.8 independently are a substituent belonging to the group comprising --Br, --CF.sub.3, --CN, --Si(C.sub.1 -C.sub.4 alkyl).sub.3, --S--(C.sub.m H.sub.2m O)--.sub.n R.sup.11 or --O--C.sub.m H.sub.2m --O--R.sup.11, or each one of R.sup.5 to R.sup.8 is --F or --Cl and at least one further member of R.sup.5 to R.sup.8 is a substituent of the groups defined above, including C.sub.1 -C.sub.4 alkyl and methoxy, R.sup.9 and R.sup.10 independently of one another are H, C.sub.1 -C.sub.12 alkyl, phenyl or --C.sub.m H.sub.2m --O--.sub.q R.sup.11, or R.sup.9 and R.sup.10 together are tetramethylene, pentamethylene, 3-oxapentylene or --CH.sub.2 CH.sub.2 NR.sup.9 CH.sub.2 CH.sub.2 --, R.sup.11 is H or C.sub.1 -C.sub.12 -alkyl, m is a number from 2 to 4, n is a number from 2 to 20 and q is a number from 1 to 20, orb) R.sup.1 to R.sup.8 independently of one another are H or one of the substituents defined above, including C.sub.1 -C.sub.4 alkyl and methoxy, or --COOR.sup.9 or --CONR.sup.9 R.sup.10 or two pairs of adjacent radicals of R.sup.1 to R.sup.8 are --CO--O--CO-- or --CO--NR.sup.9 --CO--, and at least one of R.sup.1 to R.sup.4 and also R.sup.5 to R.sup.8 is a substituent, with the exception of R.sup.2, R.sup.3, R.sup.6 and R.sup.7 when these are --F and methyl, and where R.sup.9 and R.sup.10 are as defined above.With electron acceptors they form charge-transfer complexes which can be used as organic electrical conductors, displays, optical switches and sensors.

    Benzofuran-2(3H)-ones used as anti-inflammatory agents
    28.
    发明授权
    Benzofuran-2(3H)-ones used as anti-inflammatory agents 失效
    用作抗炎剂的苯并呋喃-2（3H） - 酮

    公开(公告)号：US4514415A

    公开(公告)日：1985-04-30

    申请号：US435594

    申请日：1982-10-21

    申请人： Paul Wenk ,  Werner Breitenstein ,  Marcus Baumann

    发明人： Paul Wenk ,  Werner Breitenstein ,  Marcus Baumann

    IPC分类号： A61K31/34 ,  A61K31/343 ,  A61P25/04 ,  A61P29/00 ,  C07C59/76 ,  C07D307/83 ,  C07D471/04 ,  A61K31/365

    CPC分类号： C07D471/04 ,  C07C59/76 ,  C07D307/83

    摘要： The invention relates to novel lactones, especially benzofuranones of the general formula ##STR1## in which R.sub.1 represents hydrogen or an aliphatic radical, R.sub.2 represents an amino group di-substituted by two monovalent hydrocarbon radicals, and the aromatic ring A may be additionally substituted, and their salts and/or isomers, processes for the manufacture of compounds of the formula (I) and their salts and isomers, pharmaceutical preparations containing these compounds, and their use as the active ingredients of medicaments and/or for the manufacture of pharmaceutical preparations.

    摘要翻译： 本发明涉及新的内酯，特别是通式为（Ⅰ）的苯并呋喃酮，其中R1代表氢或脂族基团，R2代表由两个一价烃基二取代的氨基，芳环A可以是 （I）化合物及其盐和异构体的方法及其盐和/或异构体，含有这些化合物的药物制剂及其作为药物和/或制备用活性成分的用途的方法 的药物制剂。